Traws Pharma
TRAW
TRAW
26 hedge funds and large institutions have $1.37M invested in Traws Pharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$101K | |
| 2 | +$12K | |
| 3 | +$10.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.16K |
| 5 |
Millennium Management
New York
|
+$2.62K |
Top Sellers
| 1 | -$58K | |
| 2 | -$22.2K | |
| 3 | -$11.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$7.78K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$681 |